Here's the live share price of Epigral along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Epigral has gained 24.84% CAGR. Over the past year, the corresponding return has been -34.00%.
Epigral’s current P/E of 13.19x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Epigral | -8.03 | -18.11 | -27.36 | -31.99 | -34.00 | -0.42 | 24.84 |
| UPL | 0.70 | 4.71 | 19.92 | 18.95 | 57.13 | 4.58 | 11.91 |
| PI Industries | -1.51 | -5.84 | -9.25 | -22.26 | -14.55 | -2.32 | 7.62 |
| Sumitomo Chemical India | 0.39 | -2.38 | -13.28 | -12.74 | -13.68 | -1.83 | 9.55 |
| Bayer Cropscience | 2.12 | -1.08 | -5.35 | -27.59 | -17.02 | -2.71 | -3.67 |
| Atul | -0.61 | 4.26 | -0.07 | -19.01 | -11.60 | -9.88 | -1.32 |
| Sharda Cropchem | -6.42 | -4.10 | 1.66 | 2.96 | 7.01 | 17.54 | 25.36 |
| Rallis India | 0.89 | 5.01 | -8.96 | -14.18 | -5.13 | 4.63 | -0.39 |
| Dhanuka Agritech | -1.92 | -6.02 | -24.09 | -33.34 | -21.88 | 18.03 | 8.22 |
| NACL Industries | -4.78 | -7.01 | -11.34 | -19.29 | 164.11 | 18.98 | 31.58 |
| Bharat Rasayan | -5.73 | -14.49 | -9.67 | -18.98 | -10.76 | -3.67 | -2.16 |
| Bhagiradha Chemicals & Industries | -2.79 | -7.44 | -10.91 | -25.34 | -24.51 | 20.00 | 46.51 |
| Insecticides (India) | 0.37 | -2.62 | -5.55 | -26.81 | 3.64 | -2.05 | 17.85 |
| India Pesticides | -0.60 | -1.52 | -16.01 | -21.97 | -2.62 | -11.56 | -12.66 |
| Meghmani Organics | -2.79 | -6.18 | -21.47 | -35.87 | -15.67 | -16.99 | -7.70 |
| Astec Lifesciences | -3.80 | -14.38 | -12.32 | -23.49 | -27.80 | -26.12 | -11.22 |
| Punjab Chemicals and Crop Protection | -3.47 | -14.93 | -11.43 | -6.41 | 20.54 | 1.81 | 8.73 |
| 3B BlackBio Dx | -0.77 | 13.98 | 4.38 | -1.31 | -24.89 | 45.52 | 32.61 |
| Excel Industries | -2.55 | -3.06 | -19.83 | -26.76 | -26.08 | -7.02 | 1.74 |
| Heranba Industries | -5.97 | -5.08 | -17.92 | -29.95 | -40.16 | -21.67 | -21.64 |
Over the last one year, Epigral has declined 34.00% compared to peers like UPL (57.13%), PI Industries (-14.55%), Sumitomo Chemical India (-13.68%). From a 5 year perspective, Epigral has outperformed peers relative to UPL (11.91%) and PI Industries (7.62%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,331.18 | 1,302.5 |
| 10 | 1,376.44 | 1,342.6 |
| 20 | 1,419.69 | 1,391.86 |
| 50 | 1,524.49 | 1,493.83 |
| 100 | 1,656.45 | 1,595.11 |
| 200 | 1,741.25 | 1,675.74 |
In the latest quarter, Epigral remained same as its previous close in promoter holding, while DII stake increased to 4.93%, FII holding fell to 2.71%, and public shareholding moved up to 23.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 4,94,874 | 0.51 | 74.81 | |
| 4,59,048 | 0.38 | 69.39 | |
| 2,50,650 | 2.2 | 37.89 | |
| 2,13,965 | 0.62 | 32.35 | |
| 1,21,645 | 0.44 | 18.39 | |
| 76,350 | 1 | 11.54 | |
| 17,300 | 1.06 | 2.62 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Dec 22, 2025, 11:27 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 28, 2025, 8:07 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 26, 2025, 11:37 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 21, 2025, 4:42 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 17, 2025, 3:57 PM IST | Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Epigral Ltd. is a Public Limited Listed company incorporated on 11/09/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2007PLC051717 and registration number is 051717. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 2550.13 Cr. and Equity Capital is Rs. 43.14 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Epigral is ₹1,230.00 as on Dec 30, 2025.
The Epigral is operating in the Chemicals Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Epigral is ₹5,306.38 Cr as on Dec 30, 2025.
Today’s highest and lowest price of Epigral are ₹1,245.00 and ₹1,226.00.
The 52-week high/low is the highest and lowest price at which Epigral stock has traded in the past 52-week or nearly a year. The 52-week high of Epigral is ₹2,114.30 and 52-week low of Epigral is ₹1,247.10 as on Dec 30, 2025.
The Epigral has shown returns of -1.76% over the past day, -18.11% for the past month, -27.36% over 3 months, -34.0% over 1 year, -0.42% across 3 years, and 24.84% over 5 years.
P/E ratio of and PB ratio of Epigral are 13.19 and 2.53 on Dec 30, 2025. While the company gives a dividend yield of 0.49 per annum.